Trading with Jerry Olson(OJ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Trading with Jerry Olson(OJ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dominick who wrote (1442)	3/1/2004 8:15:47 AM
From: 2MAR$	of 1617

almost 9mil short =SEPR ...lord it can be a cruel market sometimes <g> SEPR upgraded at Deutsche (29.59 ) -- Update -- Deutsche Bank upgrades Sepracor to Buy from Hold and raises their target to $39 from $28 following the FDA's issuance of an approvable letter for Estorra (7:09); firm cites several positive factors related to this: 1) no further clinical or preclinical trials are needed for final approval, 2) no short-term limitation in usage as there is with mkt leader Ambien, 3) inclusion of the co's 6-month chronic use study in the draft label, and 4) approval of three dosage strengths vs expectations of two; firm says Estorra's approvability creates a near-term pathway to profits and reduces concerns over the co's debt.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next